-

China Insider

China Business

Exclusive | China challenges US in AI drug race, but rivals still reliant on each other

While US biotech firms increase use of Chinese clinical data, Chinese firms need US counterparts for monetisation, investor and scientist says.

Citic Securities claims top spot in Asia-Pacific investment banking for 2025

Yuan rapidly gaining ground as Chinese firms plot global expansion

Yuan’s use in cross-border payments rose 14 per cent year on year to 35 trillion yuan (US$4.9 trillion), according to the People’s Bank of China.

Advertisement
Advertisement
Advertisement

Trump’s tariffs: will Chinese pharmaceutical industry feel the pain?

With biotech firms caught in the crosshairs of Trump’s tariffs, the levy could prove to be a boon for domestic producers but a bane for exporters.

Employees of Jiangxi Banbiantian Pharmaceutical pack medicines at the company’s plant in Jiangxi province. Photo: VCG via Getty Images
Advertisement
Advertisement
Advertisement
OPINION
Jane Lee

Opinion | Why Hong Kong must be careful about cutting university funding

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement